Search bioRxiv⌕ Search

bioRxiv · 10.64898/2025.12.08.691908

Systematic Errors in DC Offset Measurement and Mitigation at Neurostimulation Electrodes: Causes, Implications and Solutions

Abstract

Objective: Neuromodulation therapies are becoming increasingly common as a therapeutic strategy to treat neurological disorders and deficits. Despite their widespread use, the frameworks used to evaluate device longevity and electrochemical safety are limited, producing variable results for platinum (Pt) electrodes across studies. In addition, next-generation neuromodulation electrodes like thin-film microelectrode arrays (TFMEAs) are more prone to failure by virtue of their smaller size, higher edge to bulk ratios, and greater sensitivity to electrochemical dissolution processes. Two potential contributors to the variability in reported electrochemical safety limits and device performance are particularly sensitive to scaling electrodes to smaller geometries, namely: 1) insufficient measurement device input impedance and 2) unmitigated stimulator leakage currents. Approach: To explore these effects, we first characterize the impact of electrode size (1.27 x 10-4 to 7.85 x 10-3 cm2) on apparent open circuit potential (VaOCP) and interpulse potential (VIPP) measurements at platinum electrodes across measurement instrumentation configurations. Next, we evaluated the effectiveness of commonly used DC mitigation strategies, including stimulation with capacitive coupling (CC), and with capacitive coupling combined with cathode/anode shorting after each pulse (CC+ES), as a function of electrode size. Main Results: Without proper DC mitigation, insufficient measurement input impedance leads to an underestimation of DC offsets ({Delta}VIPP) and, consequently, a misrepresentation of charge injection limits (Qinj) at Pt electrodes. In contrast, when DC offsets are properly mitigated and the input impedance of the measurement device is sufficient, the experimentally derived charge injection limits for Pt electrodes are larger than what has been reported historically. Significance: By identifying the instrumentation-related confounds biasing measurements of electrochemical safety limits, this work provides a more consistent basis for the assessment of Qinj for safety, as well as a framework for identifying and mitigating DC offset as a potential source of variability in electrophysiological findings across studies using TFMEAs.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gholston, A. K., Sanchez, R. A., Bigger, T. B., Averbeck, S. R., Rieth, L., Ludwig, K. A., Trevathan, J. K.. 2025-12-11. Systematic Errors in DC Offset Measurement and Mitigation at Neurostimulation Electrodes: Causes, Implications and Solutions. https://doi.org/10.64898/2025.12.08.691908

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗